This work reports on the use of two different Monte Carlo codes (GEANT4 and MCNPX) for assessing the dose reduction using bismuth shields in computer tomography (CT) procedures in order to protect radiosensitive organs such as eye lens, thyroid and breast. Measurements were performed using head and body PMMA phantoms and an ionisation chamber placed in five different positions of the phantom. Simulations were performed to estimate Computed Tomography Dose Index values using GEANT4 and MCNPX. The relative differences between measurements and simulations were <10 %. The dose reduction arising from the use of bismuth shielding ranges from 2 to 45 %, depending on the position of the bismuth shield. The percentage of dose reduction was more significant for the area covered by the bismuth shielding (36 % for eye lens, 39 % for thyroid and 45 % for breast shields).
INTRODUCTION
The use of computed tomography (CT), which started in the early 1970s, and its dissemination in clinical practice in the following decades very positively impacted diagnostic radiology worldwide (1, 2) . The introduction of multidetector CT (MDCT) systems provides better image quality with improved spatial resolution but results in higher doses to the patients (1, 2) . Therefore, it is extremely important to perform the dosimetric assessment of CT examinations and develop methods to reduce patient doses during CT scans.
According to ICRP Publication 103, the tissue weighting factor for breast and thyroid are 0.12 and 0.04, respectively. The eye lens is also considered an organ at risk to low-dose radiation, especially because of cataract induction (3) . The use of bismuth-impregnated latex shields is a method to protect the organs at risk from direct exposure in CT procedures (4 -8) . Chang et al. (5) showed the effective performance of bismuth shielding to reduce the unnecessary radiation dose of CT examinations while preserving image quality. Hopper et al. (6) determined a reduction of 50 % in dose to the eye lens during a cranial CT scan.
Monte Carlo simulations can make a very important contribution in assessing absorbed doses in organs, providing information that is not assessed from measurements. In this study, state-of-the-art Monte Carlo computer programs, MCNPX (Monte Carlo N-Particle eXtended) and GEANT4 (GEometry ANd Tracking), are used. The MCNPX code is a well-established method to assess the Computed Tomography Dose Index (CTDI) and absorbed doses in CT scans (5, 7, 9) . GEANT4 is an object-oriented software toolkit for the simulation of the transport of particles through matter, and it is used in a variety of application domains, including medical physics and radiation protection. Its functionality and modelling capabilities continue to be studied (10) . The main objectives of this work are (i) to evaluate the effectiveness of bismuth shielding on dose reduction during CT examinations for three different types of shields (eye lens, thyroid and breast) and (ii) to benchmark two MC codes-GEANT4 and MCNPX-in the MC computation of CTDIs for the assessment of radiation dose reduction using bismuth shielding in CT scans.
MATERIALS AND METHODS

Dose measurements
The measurements were carried out on a GE# Brightspeed Elite CT scanner using standard head and body PMMA phantoms, with diameter of 16 and 32 cm, respectively, and length of 15 cm (ProProject w ). Each phantom has four peripheral holes (designated in sequence at 08, 908, 1808 and 2708) and one central hole where a pencil ionisation chamber (IC) (RaySafe TM ) can be placed. Commercial bismuth shields for the eye lens, thyroid and breast (Kiran#) were utilised in this study (0.06-mm Pb equivalence at 120 kVp).
The measurements were performed five times for each hole with and without bismuth shielding in order to calculate the dose reduction due to the use of shields. The eye and thyroid shields were used for the head phantom and the breast shield for the body phantom. Each phantom was positioned aligning the centre of the phantom with the rotation axis of the gantry (Figure 1 ). The CT examination was made at 120 kVp, 200 mAs (head), 300 mAs (body) and 10 mm of collimation for a complete rotation of 1 s (one slice).
Computational CT model
Two MC codes were used for the purpose of this work-GEANT4 and MCNPX. The GEANT4, an object-oriented Cþþ computer language program, provides comprehensive detector and physics modelling capabilities inserted in a flexible structure (10) . MCNPX is a state-of-the-art computer code for particle transport simulation, with the capability of tracking 34 particle types at nearly all energies, and simulation of different geometries using input cards.
The focal spot of the system is located 54 cm from the centre of the CT gantry. The program SRS-78 (IPEM) (11) was used to simulate a typical X-ray energy spectrum of 120 kVp. The scanner comprises an X-ray beam filtration that includes both head and body bowtie filters and a collimator. The collimator forces the fan beam to be 558 in the x-y plane and 10-mm collimation in the z plane. In the absence of detailed information, the shape and dimensions of a typical bowtie were initially implemented in the CT model and its geometry/shape was adjusted by a trial and error iterative method until the relative differences between the measurement and the simulations were ,10 %. The CT scanner model simulated in GEANT4 is shown in Figure 2 .
In the MCNPX code, the tally F6:p results are normalised per source particle. In order to convert the units from MCNPX results (MeV/g/particle) into units of absorbed dose (mGy), a conversion factor is required. The CF used in this study has been described in a previous paper by Gu et al. (12) as a function of beam energy E and collimation NT. The CF is defined in Equation 1, where CTDI (100, air, measured)E,NT (mGy) is taken in air by the IC at the scanner isocentre, and CTDI (100, air, simulated per particle)E,NT (Mev g 21 per particle) is obtained by simulating the IC placed on the phantom under the same conditions. ðCFÞ E;NT ¼ ðCTDI 100; air; measured Þ E; NT ðCTDI 100; air; simulated per particle Þ E;NT :
ð1Þ Then, the absolute value for the simulated dose (mGy) is obtained multiplying the simulated dose in MeV g 21 per particle by the CF value, as described in the following equation:
GEANT4 can calculate directly the mean absorbed dose per particle. Nevertheless, in order to know the total absorbed dose in the sensitive volume of the ionisation chamber, the results have to be normalised by the same method described earlier. The geometry and material composition of the bismuth shields were also implemented in GEANT4 and MCNPX.
RESULTS AND DISCUSSION
Validation of the CT scanner model
Two sets of measurements were performed in order to validate the CT scanner model implemented in GEANT4 and MCPNX, including the ionisation chamber, the CTDI phantoms and free-in-air measurements. In the first set, a single axial free-in-air measurement using an IC was made, in order to obtain the conversion factor (CF). The second set of measurements used to validate the CT model comprises the CTDI phantom and the IC placed in the centre and in the four peripheral insert positions of the phantom. The measurements were performed for both the head and body phantoms, as well as for the two bowtie filters available (head and body). The CTDI 100 values for measurements and for Monte Carlo simulation obtained with MCNPX and GEANT4 are displayed in Table 1 (for 200 mAs) and Table 2 (for 300 mAs) for the head and body phantom without bismuth, respectively. The results of Table 1 show good agreement between simulations and measurements, with a maximum percentage difference of 8 % between GEANT4 and measurements. The measured CTDI 100 for the 08 position (the position representing superficial organs) of the head phantom was 36.4 mGy for measurements, 34.6 mGy for MCNPX and 34.4 mGy for GEANT4.
Regarding the measurements with the body phantom (Table 2) , the value obtained for the 08 position was 32.9 mGy. With MCNPX and GEANT4, the values for position 08 were 32.6 and 33.0 mGy, respectively. The two MC codes show a maximum percentage difference of 6 % For the measurements without bismuth shielding, the highest dose value was obtained for the position 08 of the head phantom. The lowest value corresponds to the 1808 position, because the radiation attenuation induced by CT table. For the simulation studies, this was not verified, and the highest dose value in the centre was slightly .08 ( Figure 3 ). Tables 3 and 4 show the measured and simulated CTDI 100 values in the head phantom with eye lens and thyroid bismuth shielding, respectively. The relative differences between measurements and simulations are ,10 %. The main complication in setting up an MC simulation arises from the need to validate and define the geometry and the experimental set-up with high accuracy. Consequently, the relative differences obtained are mainly due to uncertainties of X-ray spectra (%15 %) (11) , filtration, properties of materials and geometry.
Dose measurements with bismuth shielding
Using the eye lens bismuth shielding, the obtained CTDI values for the 08 position are 23.2 mGy (measurements), 21.9 mGy (MCNPX) and 21.9 mGy (GEANT4). Using the thyroid bismuth shield, the obtained values are 22.0 mGy (measurements), 21.4 mGy (MCNPX) and 21.1 mGy (GEANT4). The last column of the tables indicates a relative difference between the two MC programs up to 5 %, except for the central hole with the eye lens bismuth shield (relative difference of %7 %). Table 5 presents the CTDI 100 values for measurements and simulations with GEANT4 and MCNPX, in the body phantom with breast shielding. The CTDI 100 values for the 08 position with the breast shield were 17.9, 16.7 and 17.3 mGy for measurements, MCNPX and GEANT4 simulations, respectively. Figures 4 -6 show the percentage of dose reduction using the three different types of bismuth shields. In all cases, the major dose reduction is for the ionisation chamber inserted in the 08 position, which was expected since this corresponds to the position adjacent to the bismuth shielding. For measurements, the dose reduction at the 08 position was 36, 39 and 45 % for eye lens, thyroid and breast bismuth shields, respectively. The dose reduction at the centre was approximately half of those at 08, and one-third at the lateral positions (908 and 2708). These results indicate the effect of the area covered by the shields on the absorbed dose.
In general, there is a good agreement between the measurements and the Monte Carlo simulations for the three cases. Previous studies have demonstrated similar results and conclusions supporting the efficacy of bismuth shields on dose reductions. In fact, McLaughlin et al. (13) recommend the use of thyroid shields in routine practice. Catuzzo et al. (8) demonstrate that the use of a bismuth shield reduces significantly both organ and effective radiation dose with a consequent reduction in the risk for the patient. A good agreement, ,5 %, between the GEANT4 and MCNPX Monte Carlo simulation results, is also observed.
Additional work is necessary to corroborate these results and give more detailed information about the dose reduction in the organs of interest. Some authors have demonstrated that other techniques, such as automatic tube modulation and automatic exposure control, show good results in dose reduction without degradation of image quality and could offer a better option than bismuth (14, 15) . 
CONCLUSIONS
In this study, the effectiveness of bismuth shielding on dose reduction for radiosensitive organs during CT examinations was assessed for three different types of shields (eye lens, thyroid and breast). The highest dose reduction was obtained for breast bismuth shields. The results are useful to understand the effect of such shields on primary radiation to the patients exposed in CT scans. However, additional work is necessary in order to understand the effect on image quality and to assess the effective absorbed dose in organs. A good agreement was achieved between the two Monte Carlo computer programs used, with relative differences between them being ,5 %, as well as between the measured and the simulated doses. Therefore, the validated computational models can be used, in the future, to perform the dosimetric assessment of more complex scenarios including the implementation of human voxel phantoms, tube current modulation and other dose reduction techniques.
